Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by longonMJon Aug 28, 2018 5:26pm
132 Views
Post# 28532263

RE:RE:Tillray up after reporting - 9%!!!!!

RE:RE:Tillray up after reporting - 9%!!!!!
SouthernTierTom wrote: Indeed


Yes, totally surprising and irrational 12% after hours upside reaction from my point of view. Especially considering that they had a top-line sales revenue of only a meagre $9.7M coupled with a quarterly loss of $12.8M.

Sure, there was close to a doubling of their top-line revenues at 97% year over year, but this was achieved only through a quintupling of their net loss situation form $2.4M in the same quarter for 2017 as compared to $12.8M for this current quarter.

If their market cap is now approahing $6B USD with these absolutely poor financial results, than I don't see why the analysts and so-called experts are saying that Canopy and Aurora are overvalued considering that their top-line numbers are a lot higher and the bottom-line number is much better, at least for Aurora.  Not so much for Canopy with respect to their bottom-line.

Bullboard Posts